IVI RMA Global and Lavima Fertility join forces in research in fertility treatments


VALENCIA, Spain and BRUSSELS, July 03, 2024 (GLOBE NEWSWIRE) -- Seeking alternatives to obtain oocytes without ovarian stimulation is a pioneering line of research in reproductive medicine. The inconveniences that the process of ovarian stimulation can generate are a current barrier for some women and couples who are considering starting a reproductive treatment. In fact, 1 out of every 5 couples do not start the search for a second child for this reason.

See the original post here:
IVI RMA Global and Lavima Fertility join forces in research in fertility treatments

Related Posts